Evolus Announces Positive Data from Pivotal Trial for First

Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse Dermal Filler Products at 2024 SCALE Meeting

20.05.2024 - Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced positive topline results from a U.S. pivotal nasolabial fold (NLF) study of dermal filler products Evolysse ... Seite 1

Related Keywords

Rui Avelar , Steven Dayan , Cold Technology , Evolysse Lift , Chief Medical Officer ,

© 2025 Vimarsana